Role of Fenofibrate in Neonatal Jaundice

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

November 20, 2023

Study Completion Date

November 30, 2023

Conditions
Neonatal Jaundice
Interventions
DRUG

Fenofibrate

full-term (37 to 41 weeks), Appropriate for gestational age weight between 2500 to 3500 gm infants and with neonatal hyperbilirubinemia not reaching the level of phototherapy were randomised to receive the drug in different doses or in the control group

OTHER

placebo

ull-term (37 to 41 weeks), Appropriate for gestational age weight between 2500 to 3500 gm infants and with neonatal hyperbilirubinemia not reaching the level of phototherapy were randomised to receive the drug in different doses or in the control group

Trial Locations (1)

Unknown

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER